Literature DB >> 10490130

Mycobacterial cutaneous manifestations: a new sign of immune restoration syndrome in patients with acquired immunodeficiency syndrome.

P del Giudice, J Durant, E Counillon, V Mondain, E Bernard, P M Roger, P Dellamonica.   

Abstract

Entities:  

Mesh:

Year:  1999        PMID: 10490130     DOI: 10.1001/archderm.135.9.1129

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


× No keyword cloud information.
  6 in total

1.  Immune reconstitution syndrome after highly active antiretroviral therapy in human immunodeficiency virus-infected thai children.

Authors:  Thanyawee Puthanakit; Peninnah Oberdorfer; Noppadon Akarathum; Pornphun Wannarit; Thira Sirisanthana; Virat Sirisanthana
Journal:  Pediatr Infect Dis J       Date:  2006-01       Impact factor: 2.129

2.  Illness of Immune Reconstitution: Recognition and Management.

Authors:  Edward M Gardner; Elizabeth Connick
Journal:  Curr Infect Dis Rep       Date:  2004-12       Impact factor: 3.725

3.  Cerebral Mycobacterium avium abscesses: Late immune reconstitution syndrome in an HIV-1-infected patient receiving highly active antiretroviral therapy.

Authors:  Claude Fortin; Danielle Rouleau
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-05       Impact factor: 2.471

4.  Leprosy and AIDS: two cases of increasing inflammatory reactions at the start of highly active antiretroviral therapy.

Authors:  P Pignataro; A da Silva Rocha; J A C Nery; A Miranda; A M Sales; H Ferrreira; V Valentim; P N Suffys
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-04-27       Impact factor: 3.267

5.  Immune Restoration Inflammatory Syndromes: The Dark Side of Successful Antiretroviral Treatment.

Authors:  Matthias Stoll; Reinhold E. Schmidt
Journal:  Curr Infect Dis Rep       Date:  2003-06       Impact factor: 3.725

6.  Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options.

Authors:  David M Murdoch; Willem D F Venter; Annelies Van Rie; Charles Feldman
Journal:  AIDS Res Ther       Date:  2007-05-08       Impact factor: 2.250

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.